DocGo Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
DocGo Inc. (DCGO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $3.06 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-17
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $945.64K, a 45.42% decline year-over-year.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $2.11M, a 64.56% decline year-over-year.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $2.46M, a 17.91% decline year-over-year.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $1.56M, a 70.19% decline year-over-year.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $11.72M, a 16.14% decline from fiscal 2024.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $13.97M, a 83.34% increase from fiscal 2023.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $7.62M, a 51.37% increase from fiscal 2022.
- DocGo Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $5.04M, a 4.49% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $945.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $3.06M 10-Q · filed 2026-08-17 | $5.52M derived: sum of 3 quarters · filed 2026-08-17 | $7.08M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $2.11M 10-Q · filed 2026-05-11 | $4.57M derived: sum of 2 quarters · filed 2026-05-11 | $6.13M derived: sum of 3 quarters · filed 2026-05-11 | $7.87M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $4.02M derived: sum of 2 quarters · filed 2026-03-16 | $5.75M derived: sum of 3 quarters · filed 2026-08-17 | $11.72M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $3.30M derived: sum of 2 quarters · filed 2026-08-17 | $9.26M 10-Q · filed 2025-11-10 | $12.25M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $7.70M 10-Q · filed 2026-08-17 | $10.69M derived: sum of 3 quarters · filed 2026-08-17 | $15.93M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $5.97M 10-Q · filed 2026-05-11 | $8.96M derived: sum of 2 quarters · filed 2026-05-11 | $14.20M derived: sum of 3 quarters · filed 2026-05-11 | $17.15M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $8.23M derived: sum of 2 quarters · filed 2026-03-16 | $11.18M derived: sum of 3 quarters · filed 2026-03-16 | $13.97M 10-K · filed 2026-03-16 |
| 2024-09-30 | $5.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.19M derived: sum of 2 quarters · filed 2025-11-10 | $10.98M 10-Q · filed 2025-11-10 | $16.19M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.74M 10-Q · filed 2025-08-07 | $10.95M derived: sum of 3 quarters · filed 2026-03-16 | $11.82M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $2.79M 10-Q · filed 2025-05-08 | $8.01M derived: sum of 2 quarters · filed 2026-03-16 | $8.87M derived: sum of 3 quarters · filed 2026-03-16 | $9.49M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $6.08M derived: sum of 2 quarters · filed 2026-03-16 | $6.70M derived: sum of 3 quarters · filed 2026-03-16 | $7.62M 10-K · filed 2026-03-16 |
| 2023-09-30 | $868.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.48M derived: sum of 2 quarters · filed 2024-11-07 | $2.41M 10-Q · filed 2024-11-07 | $3.35M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $612.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $1.54M 10-Q · filed 2024-08-07 | $2.48M derived: sum of 3 quarters · filed 2025-02-27 | $4.38M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $926.47K 10-Q · filed 2024-05-08 | $1.87M derived: sum of 2 quarters · filed 2025-02-27 | $3.77M derived: sum of 3 quarters · filed 2025-02-27 | $5.24M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $940.47K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.84M derived: sum of 2 quarters · filed 2025-02-27 | $4.31M derived: sum of 3 quarters · filed 2025-02-27 | $5.04M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $3.37M derived: sum of 2 quarters · filed 2023-11-06 | $4.09M 10-Q · filed 2023-11-06 | $5.80M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $2.19M 10-Q · filed 2023-08-08 | $3.90M derived: sum of 3 quarters · filed 2024-02-28 | $5.35M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $722.72K 10-Q · filed 2023-05-09 | $2.43M derived: sum of 2 quarters · filed 2024-02-28 | $3.88M derived: sum of 3 quarters · filed 2024-02-28 | $4.54M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.16M derived: sum of 2 quarters · filed 2024-02-28 | $3.82M derived: sum of 3 quarters · filed 2024-02-28 | $5.27M 10-K · filed 2024-02-28 |
| 2021-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.12M derived: sum of 2 quarters · filed 2022-11-08 | $3.57M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $657.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $2.11M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $1.45M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.60M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |